About 2017-04-28T04:04:51+00:00

About us

Prescient Therapeutics is a clinical stage oncology company developing novel drugs that show great promise as potential new therapies to treat a range of cancers that have become resistant to front line chemotherapy.

about prescient therapeutics
prescient therapeutics company overview

COMPANY OVERVIEW

Prescient’s second novel drug candidate, PTX-100, is a first in class drug that kills cancer cells by blocking geranylgeranyl ransferase-1 (GGT-1), a protein required for the cancer-causing activity.

Read more

prescient therapeutics management team

MANAGEMENT TEAM

Find out more about the Prescient Therapeutics Management Team.

Read more

prescient therapeutics board of directors

BOARD OF DIRECTORS

Find out more about our Board of Directors.

Read more

prescient therapeutics scientific advisory board

SCIENTIFIC ADVISORY BOARD

Coming soon.